+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Elvitegravir"

Antiviral Therapeutics - Technologies, Markets & Companies - Product Thumbnail Image

Antiviral Therapeutics - Technologies, Markets & Companies

  • Report
  • November 2021
  • 620 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Elvitegravir is a drug used to treat immune disorders, such as HIV and AIDS. It is a type of integrase inhibitor, which works by blocking the action of the enzyme integrase, which is responsible for the integration of HIV DNA into the host cell. Elvitegravir is usually used in combination with other antiretroviral drugs to treat HIV infection. It is also used to prevent HIV infection in people who are at high risk of contracting the virus. Elvitegravir is available in both oral and injectable forms. It is generally well tolerated, with few side effects. Common side effects include nausea, headache, and diarrhea. Elvitegravir is generally considered to be a safe and effective treatment for HIV and AIDS. The Elvitegravir market is highly competitive, with several companies offering the drug. Some of the major players in the market include Gilead Sciences, Merck, Bristol-Myers Squibb, and GlaxoSmithKline. Show Less Read more